Adolecent Schizophrenia Study
for Pediatric schizophrenia
Challenge
- Recruit schizophrenic children, ages 13-17, for a FDA-mandated pediatric clinical study evaluating an adult-approved medication for treatment of children with schizophrenia.
Solutions
- Utilizing focus group research, develop a comprehensive information and advertising program to build awareness among family carers and adolescents.
Result
- National program supported study sites providing information tailored to both carers and potential study patients.
Project Scope: Patient recruitment
Back to list 
recruitment, pediatric, global, cns, logo, website, schizophrenia
